Lab-grown islet cells for diabetes after pancreas surgery
Part of Hormones & metabolism clinical trials.
This trial tests whether lab-grown islet cells (pancreatic organoids) can help control blood sugar in people who develop diabetes after having most or all of their pancreas removed. If successful, this could reduce the need for insulin shots.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have a pancreatic condition (like a tumor, chronic pancreatitis, injury, or cystic fibrosis) that requires removing most or all of your pancreas.
- You developed diabetes after pancreatic surgery.
- Your C-peptide level (a measure of your body's own insulin production) is very low after a mixed meal.
- You are generally healthy with no serious heart, lung, liver, or kidney disease, and no active infections like hepatitis or HIV.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether transplanting your own insulin-making cells (islets) can help control blood sugar if you have type 2 diabetes and your pancreas is not making enough insulin. The goal is to reduce or stop your need for insulin injections.
This trial tests if umbilical cord stem cells can improve the success of islet cell transplants for people with diabetes whose own pancreas no longer makes enough insulin. It aims to help patients achieve better blood sugar control and reduce dangerous low blood sugar episodes.
This trial looks at how certain cells in the pancreas work in people newly diagnosed with type 2 diabetes. It may help doctors understand the disease better and find new treatment approaches.
This study tests a new treatment called E-islet 01, which may help people with type 1 diabetes who have very low natural insulin production and have had dangerous low blood sugar events. The goal is to see if it is safe and can reduce those episodes.
This trial studies pancreatic islets (cells that make insulin) from people who are having part or all of their pancreas removed. It may help researchers learn more about how the pancreas works in health and disease.
This trial looks at whether adding gastrin can improve outcomes after an islet cell transplant for people with type 1 diabetes. It may help some participants achieve better blood sugar control, but it also requires close follow-up and immune-suppressing medications to protect the new cells.
Hear when a new T3c Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.